rewirebio.iobenchmarks
Source

Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed · Preprint

DOI: 10.64898/2026.03.02.709004

Authors: Smorodina, Ali, Kropivšek Brumat, Salicari, Miklavc, Kappassov, Fu, Sormanni, de Marco and Greiff. None developed AlphaFold3, Boltz-2 or Chai-1. Competing interests printed: V.G. declares advisory, consulting and employment roles with antibody-discovery and biotechnology companies, none of them a developer of the three tools compared.

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 1 samples)0.24 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 100 samples)0.68 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Pearson (change in ipTM against change in DockQ under saturation sampling)-0.027 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Pearson (ipTM against DockQ for the best-DockQ sample of each complex)0.736 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Pearson (ipTM against DockQ for the first sample (sample0) of each complex)0.888 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Proportion (share of predictions with ipTM at least 0.5 and DockQ below 0.23 (confident failures, Q2))2% percentSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Proportion (share of predictions with ipTM below 0.5 and DockQ at least 0.23 (unconfident successes, Q4))28% percentSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesAF3 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
AlphaFold3 3.0.1, 50 diffusion samples, seed 1, built-in data pipeline (Smorodina et al. 2026)Average precision (cognate against shuffled pairs ranked by ipTM)0.187 unitlessSmorodina et al. 2026 all-against-all VHH-antigen pairing matrix (91 unique PDB entries)AF3 on Telling cognate from shuffled nanobody-antigen pairs by ipTM (Smorodina et al. 2026)
Boltz-1 via Boltz CLI v2.2.0, MSA server (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 1 samples)0.06 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-1 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-1 via Boltz CLI v2.2.0, MSA server (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 100 samples)0.26 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-1 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 1 samples)0.57 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 100 samples)0.80 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)Pearson (change in ipTM against change in DockQ under saturation sampling)-0.040 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)Pearson (ipTM against DockQ for the best-DockQ sample of each complex)0.665 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)Pearson (ipTM against DockQ for the first sample (sample0) of each complex)0.493 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)Proportion (share of predictions with ipTM at least 0.5 and DockQ below 0.23 (confident failures, Q2))18% percentSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesBoltz-2 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Boltz-2 via Boltz CLI v2.2.0, 50 diffusion samples, seed 42, MSA server (Smorodina et al. 2026)Average precision (cognate against shuffled pairs ranked by ipTM)0.026 unitlessSmorodina et al. 2026 all-against-all VHH-antigen pairing matrix (91 unique PDB entries)Boltz-2 on Telling cognate from shuffled nanobody-antigen pairs by ipTM (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 1 samples)0.04 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesChai-1 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)DockQ (median over complexes of the best DockQ among N = 100 samples)0.19 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesChai-1 on Best DockQ against sampling depth on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)Pearson (change in ipTM against change in DockQ under saturation sampling)-0.019 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesChai-1 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)Pearson (ipTM against DockQ for the best-DockQ sample of each complex)0.612 unitlessSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesChai-1 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)Proportion (share of predictions with ipTM below 0.5 and DockQ at least 0.23 (unconfident successes, Q4))24% percentSmorodina et al. 2026 nanobody-antigen benchmark: 106 cognate VHH-antigen complexesChai-1 on How well ipTM tracks DockQ on cognate nanobody-antigen complexes (Smorodina et al. 2026)
Chai-1 0.6.1, 5 trunk x 10 diffusion samples, seed 42, ESM embeddings without MSAs (Smorodina et al. 2026)Average precision (cognate against shuffled pairs ranked by ipTM)0.067 unitlessSmorodina et al. 2026 all-against-all VHH-antigen pairing matrix (91 unique PDB entries)Chai-1 on Telling cognate from shuffled nanobody-antigen pairs by ipTM (Smorodina et al. 2026)

Claims

Statements this source supports, each with where in the source it was checked.

  • baseline: structural-20261009-protocol-smorodina2026-vhh-cognate-vs-shuffled: Baseline Random baseline precision is about 0.011: about 89 to 91 positives out of about 8041 to 8281 evaluated pairs, depending on the tool after excluding missing values. (Results P11)
  • Evidence summary: structural hypotheses for experiments: Summary Two new comparisons join the existing docking and FoldBench evidence, both on antibody complexes, and neither ties a prediction to an experiment's outcome. Fromm et al. 2026 generated 200 AlphaFold3 models for each of 110 antibody-antigen complexes deposited after the training cutoff, then asked which model each confidence score picks. Every score a user can compute picked models of about the same quality: mean DockQ 0.375 for ranking confidence, 0.370 for ipTM, 0.369 for pTM, 0.353 for ipSAE and 0.352 for pDockQ2, while the best of the 200 models averaged 0.544. The per-target correlation between score and accuracy stayed at or below 0.247, so within one target the confidence ranking carried little information. Smorodina et al. 2026, a bioRxiv preprint that has not been peer reviewed, ran AlphaFold3, Boltz-2, Boltz-1 and Chai-1 on 106 nanobody-antigen complexes. Sampling raised the best available model for every tool, with median best DockQ rising from 0.24 to 0.68 for AlphaFold3 and from 0.57 to 0.80 for Boltz-2 between 1 and 100 samples, though picking that best sample needs the experimental structure. Confidence tracked accuracy unevenly: the correlation between ipTM and best-sample DockQ was 0.736 for AlphaFold3, 0.665 for Boltz-2 and 0.612 for Chai-1, with 18% of Boltz-2 predictions confident but wrong and 24% of Chai-1 predictions accurate but unconfident. Pairing every nanobody with every antigen showed that confidence does not indicate that an interaction exists at all: average precision for ranking the real pairings above shuffled ones was 0.187 for AlphaFold3, 0.067 for Chai-1 and 0.026 for Boltz-2, against a baseline of about 0.011. The preprint's nanobody set mixes systems inside and outside each tool's training data, and its non-cognate pairings are assumed not to bind rather than tested. A high confidence score is a statement about a predicted structure, not evidence that two molecules interact. (structural-20261009-source-fromm2026: Table 1, sections 2.1 and 2.2; structural-20261009-source-smorodina2026: Results P8, P11, P19 and P36)
  • negative_definition: structural-20261009-protocol-smorodina2026-vhh-cognate-vs-shuffled: Negative definition The source states: 'we assume that VHHs and antigens of “shuffled complexes” are non-binders'. Negatives are therefore pairings assumed not to bind, not pairings shown not to bind. (Results P9)
  • Relevance of structural-20261009-protocol-smorodina2026-vhh-cognate-vs-shuffled to "Which predicted interfaces or structures are reliable enough to guide my next experiment?": Assessed by Telling cognate from shuffled nanobody-antigen pairs by ipTM (structural-20261009-source-smorodina2026: Results P9 to P11; Figure 2)
  • Relevance of structural-20261009-protocol-smorodina2026-vhh-dockq-vs-sampling to "Which predicted interfaces or structures are reliable enough to guide my next experiment?": Assessed by Best DockQ against sampling depth on cognate nanobody-antigen complexes (structural-20261009-source-smorodina2026: Results P33 to P36; Methods P83 and P91; Figure 5B)
  • Relevance of structural-20261009-protocol-smorodina2026-vhh-iptm-dockq-calibration to "Which predicted interfaces or structures are reliable enough to guide my next experiment?": Assessed by How well ipTM tracks DockQ on cognate nanobody-antigen complexes (structural-20261009-source-smorodina2026: Results P18 to P22; Figure 3)

Models, benchmarks and other records

Configurations (4)

Protocols (3)

Datasets (2)

Evaluations (10)

Use cases (1)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

23 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance
Access and reuse
CC BY 4.0 permits redistribution of the article bytes.
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.access_and_reuse

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Archive note
Gzip copy (gzip -n -9) archived in the batch as artifacts/smorodina2026-article.xml.gz.
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.archive_note

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Artifact SHA-256
0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PPR1221387/fullTextXML
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Doi
10.64898/2026.03.02.709004
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Extraction method
JATS XML parse (xml.etree), by extract/extract_structural.py
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.extraction_method

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Licence
CC-BY-4.0
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.licence

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Media type
application/xml
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.media_type

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Publication status
preprint
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

Retrieval note
bioRxiv returned HTTP 429 (Cloudflare 1015) for the source XML, and the Europe PMC supplementary files returned a browser challenge, so only the Europe PMC full text was read. Supplementary Tables 1, 3 and 4 were not read.
Source metadata
Structural Plausibility Without Binding Specificity: Limits of AI-Based Antibody-Antigen Structure Prediction Confidence Scores

Original source ↗

No field-specific location recorded

Version: bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
Retrieved: 2026-10-09T21:25:48Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieval_note

Source artifact SHA-256: 0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732

Hash scope: JATS XML parse (xml.etree), by extract/extract_structural.py

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

Primary source retrieved and hashed for the structural hypotheses use-case pass.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: structural-20261009-source-smorodina2026

areas
proteins-complexes
contexts
research
url
https://doi.org/10.64898/2026.03.02.709004
artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PPR1221387/fullTextXML
version
bioRxiv version 1, posted 2026-03-03; Europe PMC preprint full text PPR1221387 (manuscript EMS215481); not peer reviewed
retrieved at
2026-10-09T21:25:48Z
artifact sha256
0ad24054d98fd1888fa8bf3120f76e22f7bf6b1965261b16f045986d72c50732
publication status
preprint
licence
CC-BY-4.0
media type
application/xml
doi
10.64898/2026.03.02.709004
source locator
Full artifact bytes; per-record locators on each record
access and reuse
CC BY 4.0 permits redistribution of the article bytes.
archive note
Gzip copy (gzip -n -9) archived in the batch as artifacts/smorodina2026-article.xml.gz.
extraction method
JATS XML parse (xml.etree), by extract/extract_structural.py
scope note
Authors: Smorodina, Ali, Kropivšek Brumat, Salicari, Miklavc, Kappassov, Fu, Sormanni, de Marco and Greiff. None developed AlphaFold3, Boltz-2 or Chai-1. Competing interests printed: V.G. declares advisory, consulting and employment roles with antibody-discovery and biotechnology companies, none of them a developer of the three tools compared.
retrieval note
bioRxiv returned HTTP 429 (Cloudflare 1015) for the source XML, and the Europe PMC supplementary files returned a browser challenge, so only the Europe PMC full text was read. Supplementary Tables 1, 3 and 4 were not read.
Related records

    Suggest a correction